The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

Stocks•6 April 2026•

1 min read

Capricorn Fund Managers Invests $4.12 Million in Pfizer After Earnings Beat

Canadian flag, a plasma bag, and "GRIFOLS" text on an orange background with medical equipment, microscopes, and vials.

Key Facts

1Capricorn Fund Managers Ltd invested $4.12 million to acquire 165,569 shares in Pfizer Inc. during the fourth quarter.

2Pfizer reported Q4 results surpassing expectations with $0.66 EPS and $17.56 billion in revenue.

3Institutional investors own approximately 68.36% of Pfizer's stock.

Capricorn Fund Managers Ltd established a new position in Pfizer Inc. during the fourth quarter, acquiring 165,569 shares. The investment is valued at approximately $4.12 million, marking a significant entry into the pharmaceutical giant's stock. This move followed Pfizer's strong fourth-quarter financial performance, which surpassed analyst estimates for both earnings and revenue. The company reported an EPS of $0.66 and total revenue of $17.56 billion, beating market expectations. Currently, institutional investors hold a dominant position in the company, owning about 68.36% of Pfizer's outstanding shares. This institutional buying activity highlights a positive sentiment toward the company's valuation following its recent earnings beat.